ARCHIVES

Phase II Study Finds Dasatinib May Overcome ALL Resistance

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer.

November 30, 2001

In Brief: In Vitro Systems Will Be 90% Reliable, Ames Says; GAO Asks For Reassessment of Saccharin

October 1, 1976

NCI To Spend About $150 Mil. On Cancers That Affect Only Women

April 26, 1991

Medicare Covers All PET Scans For Cancer In New Program

May 26, 2006

Lower Stomach Cancers Increasing In Younger U.S. Whites, Study Finds

May 28, 2010

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976